Recent findings suggesting the potential transdiagnostic efficacy of psychedelic-assisted
therapy have fostered the need to deepen our understanding of psychedelic brain action …

Psychedelic therapy has witnessed a resurgence in interest in the last decade from the
scientific and medical communities with evidence now building for its safety and efficacy in …

N, N-Dimethyltryptamine (DMT) is a serotonergic psychedelic that induces a rapid and
transient altered state of consciousness when inhaled or injected via bolus administration …

Background Pharmacological and nonpharmacological methods of inducing altered states
of consciousness (ASCs) are becoming increasingly relevant in the treatment of psychiatric …

Modern psychedelic research and clinical development is at a crucial inflection point, with
great potential for the treatment of many mental illnesses demonstrated but significant …

Developmental stuttering (DS) is a neurodevelopmental speech-motor disorder
characterized by symptoms such as blocks, repetitions, and prolongations. Persistent DS …

Psychedelic therapy (PT) is an emerging paradigm with great transdiagnostic potential for
treating psychiatric disorders, including depression, addiction, post-traumatic stress …

Neural activity and behavior vary within an individual (states) and between individuals
(traits). However, the map** of state-trait neural variation to behavior is not well …

The emerging neuroscientific frontier of brain fingerprinting has recently established that
human functional connectomes (FCs) exhibit fingerprint-like idiosyncratic features, which …

New Psychoactive Substances (NPS) are modifying the drug scenario worldwide and have
become a public health concern because of their toxicological profiles and their harmful …